Pulmonx Corporation LUNG Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Pulmonx Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulmonx Corporation's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulmonx Corporation's change in accrued liabilities?
- Pulmonx Corporation (LUNG) reported change in accrued liabilities of -$1.17M in Q1 2026.
- How has Pulmonx Corporation's change in accrued liabilities changed year-over-year?
- Pulmonx Corporation's change in accrued liabilities increased by 76.2% year-over-year, from -$4.89M to -$1.17M.
- What is the long-term trend for Pulmonx Corporation's change in accrued liabilities?
- Over 2 years (2021 to 2023), Pulmonx Corporation's change in accrued liabilities has grown at a -18.7% compound annual growth rate (CAGR), from $4.8M to $3.18M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.